glp-1 non responders Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response One in 10 people may
Description
PMID: 28507015
VNR, value not reported
The Phase 2 trial , published in the New England Journal of Medicine, tested doses from 1 mg to 12 mg over 48 weeks
[DOI] [PubMed] [Google Scholar] 12.Kreymann B, Williams G, Ghatei MA, Bloom SR
